Mersana Therapeutics

+$0.06 (+0.42%) Today
-$0.06 (-0.42%) As of 8:19 PM UTC after-hours

Why Robinhood?

You can buy or sell MRSN and other stocks, options, and ETFs commission-free!

About MRSN

Mersana Therapeutics, Inc. Common Stock, also called Mersana Therapeutics, is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need.

CEO
Anna Protopapas
Employees
110
Headquarters
Cambridge, Massachusetts
Founded
2001

MRSN Key Statistics

Market Cap
960.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
708.75K
High Today
$14.82
Low Today
$14.09
Open Price
$14.29
Volume
563.47K
52 Week High
$29.09
52 Week Low
$9.53

MRSN Earnings

-$0.50
-$0.43
-$0.37
-$0.30
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.39 per share
Actual
-$0.50 per share
Replay Earnings Call

You May Also Like

VGR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure